While many new VC firms are still struggling to raise new capital, Dimension Capital, founded in late 2022, is rapidly raising large sums of money. On Tuesday, the New York firm — which invests at the intersection of science and computing — announced an $800 million fund, 60% larger than its $500 million The second vehicle was announced just 18 months ago.
When Zavian Dar and Adam Goulburn – previously partners at Lux Capital – teamed up with Obvious Ventures alum Nan Li to launch the firm four years ago, they bet that founders would increasingly want to build deep-tech companies that push the boundaries of biotech and software. Now, all three partners admit they are impressed by how quickly their thesis is taking off.
In 2024, he co-led a $30 million seed investment in Tea Discovery. The startup, which is developing open-source AI foundation models for drug development, announced last week that it has raised funding $400 million At a valuation of $3.8 billion. The company also backed anti-aging startup New Limit in a Series A round in January 2025. Earlier this month, New Limit, co-founded by Coinbase CEO Brian Armstrong, completed a Series C at a valuation of $3.1 billion.
The firm’s other notable investments include estimation company Model Labs and Anthropic. Dimension received shares in the AI giant this spring after Anthropic acquired its portfolio company, drug discovery platform Coefficient Bio, for $$.400 million.
